It's hard to believe it's been more than 10 years ago since FitBit pioneered the fitness wearables market. As the technology has advanced, the lines between what is a consumer wellness device and what is a medical-grade wearable have begun to blur, with a number of companies sitting at the intersection of consumer wellness and medical-grade wearables. One such company is Movano.John Mastrototaro, CEO at Movano, joins the latest episode of Let's Talk Medtech to discuss that intersection of consumer and medical-grade wearables, and why he joined Movano. The Pleasanton, CA-based company is creating consumer products designed to deliver medical-grade data. Founded in 2018, the company recently announced that its first product will be a fitness ring designed specifically for women that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen, steps, and calories.Movano is currently conducting clinical trials with its radio frequency-enabled technology and developing algorithms to add medical data, including non-invasive glucose monitoring and cuffless blood pressure, to its core product in the future. The company plans to execute accuracy studies to pursue FDA clearances on its vital signs monitoring capabilities including heart rate, SpO2, and respiration rate.The Movano Ring is expected to be available through a beta release in the second half of 2022.

Something amazing is happening right now in the world of medtech. Devices are becoming mainstream and more consumer-friendly. With this new development, medical device companies have to think of a more consumer-friendly approach toward getting the message out about technologies. Nicole Osmer, Health+Commerce's CEO and founder, joins us for an insightful conversation on medtech branding.

In this Let's Talk Medtech Special, recorded at the IME West manufacturing tradeshow in Anaheim, CA April 12-14, 2022, we explore all aspects of the global supply chain crisis. You'll hear from multiple manufacturing experts who were at the show, in one succinct, narrative-style podcast episode.

Jijo James, MD, chief medical officer of medtech and global external innovation at Johnson and Johnson, talks with MD+DI News Editor Amanda Pedersen about medical device safety. He talks about the shift from reactive approaches to patient safety to a proactive approach. He also talks about how to handle situations where a use-related error is causing a safety concern, and how even those errors are the responsibility of the device manufacturer.

Embecta is now fully independent from Becton Dickinson & Co. Devdatt Kurdikar, Embecta's CEO talks about what that means going forward and his plans for the company.  With its rich pedigree and newly-independent status, Embecta is truly the new/old kid on the block in diabetes care.

Ethan Drower, co-founder and Operating Partner of CiteMed drops by to talk about how his consulting firm is helping medtech companies navigate European Union Medical Device Regulation (EU MDR). Plus he gives some stellar tips on device regulation in other geographies too.

EY Americas Leader for Health Technology, Dr. Kaushik Bhaumik joins us for this episode of Let's Talk Medtech to discuss COVID-19's impact on the healthcare system. While the virus accelerated the adoption of technology in healthcare, it also illuminated existing gaps in digital care and leveraging patient data. And if not addressed, these gaps, along with other pressing healthcare issues like nursing shortages and the Great Resignation, will only further exacerbate healthcare’s existential problem. Dr. Bhaumik speaks about the true nature of the problem and gives some insight into potential solutions.

It's been more than a month since Elizabeth Holmes, Theranos's founder and CEO, was found guilty on three counts of wire fraud and one count of conspiracy to commit wire fraud for lying to investors. There's no doubt that she has a mystique surrounding her that invites conversation. Hulu even recently released a limited series starring Amanda Seyfried as Holmes, which documents the rise and fall of Theranos. A special panel of medtech veterans discusses the mystique surrounding Holmes and the implications the trial could have on the industry in the future. Plus the panel gives some tips to entrepreneurs on how to avoid a "Theranos-like" situation.

ZimVie's CEO Vafa Jamali joins Let's Talk Medtech in an exclusive interview about how the company is poised to transform the dental and spine markets.  The company has now been completely spun out from Zimmer Biomet and is trading on the Nasdaq. With strong leadership and a strong product portfolio, ZimVie is poised to be one of the breakout companies of the year in medtech.

It's American Heart Month & Cleerly's Dr. James Min shows how the company is using artificial intelligence to change the way we diagnose cardiovascular disease.